Who invested in Swixx Biopharma

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round: VentureDec 2025
Investors: 3

See who backed them

The rounds

Dec 2025
VentureAmount undisclosed
Source recorded

Founders and team

From Swixx Biopharma's own website: 1 founder, 28 on the team.

Stuart SwansonFounder, Board Member and Head of Corporate Development

Jean-Michel LespinasseCEO
Marcela LaššákováChief Compliance Officer
Petr PípalCFO
Tina PuhaloHead of Communications
Aaron DavenportChairman of the Board
Altan GorsevalGeneral Manager Türkiye
Askar TalipovCountry Manager Kazakhstan
Bledar ShorriGeneral Manager Albania and Kosovo
Darko PopovićCorporate IT Director
Davor KovačevićGeneral Manager Croatia
Gabriela MarkovováGeneral Manager Slovakia
Gabriela ZelenkováGeneral Counsel and Company Secretary
Georgiana LevivierGeneral Manager Romania & Moldova
Gergely KovácsGeneral Manager Hungary
Ivan PertotBusiness Development Director
Ivana PrelevićGeneral Manager Montenegro
Jean-François BilletBoard Member
Jelica ČubrićCorporate Quality Director

And 10 more on the team.

Everyone who backed them

CitibankGrowth equity1round

UBSWealth manager1round

Ares ManagementGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Swixx Biopharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.